AG
RIGL icon

AmeriFlex Group’s Rigel Pharmaceuticals RIGL Stock Holding History

AmeriFlex Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35K Hold
50
– – ﹤0.01% 978
2025
Q4 		$2.14K Sell
50
-50
-50% -$1.89K ﹤0.01% 990
2025
Q3 		$2.83K Buy
100
+50
+100% +$1.5K ﹤0.01% 955
2025
Q2 		$938 Hold
50
– – ﹤0.01% 1003
2025
Q1 		$900 Sell
50
-200
-80% -$4.06K ﹤0.01% 1208
2024
Q4 		$5.41K Buy
+250
New +$4.79K ﹤0.01% 900

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AmeriFlex Group's RIGL Position: Q1 2026 in Review

AmeriFlex Group held its Rigel Pharmaceuticals (RIGL) position steady in Q1 2026 at 50 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

AmeriFlex Group first reported a position in RIGL in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.41K in Q4 2024. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • AmeriFlex Group held 50 shares of Rigel Pharmaceuticals worth $1.35K as of Q1 2026.
  • AmeriFlex Group left its Rigel Pharmaceuticals share count unchanged in Q1 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of AmeriFlex Group's portfolio in Q1 2026, its #978 holding.
  • AmeriFlex Group first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • AmeriFlex Group's Rigel Pharmaceuticals position peaked at $5.41K in Q4 2024.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.